Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy
使用布里渊显微镜确定角膜交联方案的功效
基本信息
- 批准号:10443488
- 负责人:
- 金额:$ 40.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAblationAccountingAddressAffectAnimalsBehaviorBiomechanicsClinicClinicalClinical ResearchCorneaCorneal StromaDataDevelopmentDiffusionDiseaseElasticityElementsEpithelialEvaluationEvolutionExcisionEyeFDA approvedFutureGoalsHumanHydration statusImageIn SituKeratoconusKeratoplastyLasersLongitudinal StudiesMapsMeasurementMeasuresMechanical StressMechanicsMethodsMicroscopyModelingModulusMorphologyOpticsOryctolagus cuniculusOutcomePatientsPhotorefractive KeratectomyPhotosensitizing AgentsProceduresProcessProtocols documentationPublic HealthQuality of lifeRecoveryResearchResistanceResolutionRiboflavinSafetyShapesSpatial DistributionSpeedTechniquesTechnologyTestingThickTimeTissuesTranslatingTreatment ProtocolsUltraviolet A radiationVisionVisualVisual AcuityWorkbaseclinical translationcohortcrosslinkexperimental studyhuman subjectimprovedin vivoindividualized medicinenovelpatient tolerabilitypredict clinical outcomepredictive modelingprogramsprotocol developmentpublic health relevancerational designresearch clinical testingresponsetime usetomographytreatment planning
项目摘要
ABSTRACT:
Keratoconus and related corneal ectatic diseases cause significantly decreased quality of life, are the leading
cause for full thickness corneal transplant in the US, and are significantly more prevalent than previously thought.
Corneal cross-linking (CXL) has emerged as a clinical technique to halt keratoconus progression by stiffening
the corneal stroma. Despite being used clinically for more than a decade, it is currently impossible to assess
CXL protocol efficacy or predict the long-term stability and because we lack quantitative biomechanical measures
to inform predictive models. Currently available metrics to characterize CXL responses are morphologic and
have not proven predictive of clinical outcomes. The major gap is the lack of measurement techniques that can
accurately and non-perturbatively characterize corneal mechanics with three-dimensional (3-D) resolution in
vivo. To address this need, in the past decade we have pioneered Brillouin microscopy, a high-resolution optical
technology that can measure corneal longitudinal modulus in situ in 3-D without contacting or perturbing the eye.
Brillouin microscopy has provided the first and only direct mechanical evidence of decreased modulus in
keratoconus corneas in vivo and the only 3-D maps of CXL-induced corneal stiffening. The overall goal of this
research program is to combine 3-D Brillouin corneal maps and finite element (FE) modeling to quantitatively
predict corneal shape outcomes after CXL protocols. In strong preliminary data, we demonstrated that, by
accounting for tissue hydration, we can establish the quantitative relationship between Brillouin-measured
longitudinal modulus and Young’s modulus. Thus, our central hypothesis is that spatial maps of corneal Young’s
modulus derived from quantitative Brillouin microscopy will enable accurate prediction of corneal shape behavior
via FE modeling. The development of this noninvasive measure of corneal stiffness also enables us to use a
rabbit model to evaluate, for the first time, both morphologic and mechanical evolution in longitudinal studies in
vivo, validated by direct mechanical analysis using experimental protocols that cannot be performed in human
subjects. We will test our central hypothesis through the three specific aims: 1) Validate in vivo Brillouin
mechanical measurements after CXL; 2) Quantify the in vivo mechanical outcomes of novel CXL protocols; and
3) Link CXL biomechanical impact to morphologic outcome with Brillouin imaging and FE modeling. This
research is significant because accurate nondestructive, nonperturbative elasticity-based metrics will drive a
paradigm shift in how CXL protocols are evaluated, developed, and performed clinically as well as ultimately
allow us to develop individualized CXL treatment protocols.
摘要:
圆锥角膜和相关的角膜扩张性疾病导致的生活质量明显下降,是主要的
在美国,全厚角膜移植的原因,而且比之前认为的要普遍得多。
角膜交联术(CXL)已经成为一种通过硬化来阻止圆锥角膜进展的临床技术
角膜基质。尽管已经在临床上使用了十多年,但目前还不可能对其进行评估
CXL方案的疗效或预测长期稳定性,因为我们缺乏定量的生物力学措施
为预测模型提供信息。目前可用来表征CXL反应的指标是形态和
还没有被证明可以预测临床结果。主要的差距是缺乏能够
用三维(3-D)分辨率精确和非摄动地表征角膜力学
活着。为了满足这一需求,在过去的十年里,我们开创了布里渊显微镜,一种高分辨率的光学
这项技术可以在不接触或干扰眼睛的情况下,在3D中原位测量角膜纵向模数。
布里渊显微镜提供了第一个也是唯一一个直接的力学证据
活体圆锥角膜和CXL诱导的角膜硬化的唯一三维地图。这个项目的总体目标是
研究计划是将三维布里渊角膜地图和有限元(FE)建模相结合,以定量
预测CXL手术后的角膜形态结果。在强劲的初步数据中,我们通过
考虑到组织的水合作用,我们可以建立布里渊测量之间的定量关系
纵向模数和杨氏模数。因此,我们的中心假设是角膜杨氏空间图
从定量布里渊显微镜获得的模数将使准确预测角膜形状行为成为可能
通过有限元建模。这种非侵入性角膜硬度测量的发展也使我们能够使用
首次在纵向研究中评估形态和力学演变的兔模型
活体,通过使用不能在人类身上执行的实验方案的直接力学分析进行验证
研究对象。我们将通过三个具体目标来验证我们的中心假设:1)在体内验证布里渊
CXL后的机械测量;2)量化新的CXL方案的体内机械结果;以及
3)通过布里渊成像和有限元模拟将CXL的生物力学影响与形态学结果联系起来。这
研究具有重要意义,因为准确的无损、非扰动的基于弹性的指标将推动
CXL方案在临床和最终评估、开发和执行方式的范式转变
允许我们开发个性化的CXL治疗方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Joseph Dupps其他文献
William Joseph Dupps的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Joseph Dupps', 18)}}的其他基金
Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy
使用布里渊显微镜确定角膜交联方案的功效
- 批准号:
10642876 - 财政年份:2022
- 资助金额:
$ 40.26万 - 项目类别:
Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery
用于个性化角膜疾病评估和手术的先进成像和模拟工具
- 批准号:
10644983 - 财政年份:2022
- 资助金额:
$ 40.26万 - 项目类别:
Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery
用于个性化角膜疾病评估和手术的先进成像和模拟工具
- 批准号:
10365675 - 财政年份:2022
- 资助金额:
$ 40.26万 - 项目类别:
Noninvasive assessment of the cornea by diffusion OCT
通过扩散 OCT 对角膜进行无创评估
- 批准号:
10421300 - 财政年份:2018
- 资助金额:
$ 40.26万 - 项目类别:
Noninvasive assessment of the cornea by diffusion OCT
通过扩散 OCT 对角膜进行无创评估
- 批准号:
10171859 - 财政年份:2018
- 资助金额:
$ 40.26万 - 项目类别:
Corneal Elastography and Patient-Specific Modeling for Simulation-based Therapy
用于基于模拟的治疗的角膜弹性成像和患者特异性建模
- 批准号:
8482579 - 财政年份:2013
- 资助金额:
$ 40.26万 - 项目类别:
Corneal Elastography and Patient-Specific Modeling for Simulation-based Therapy
用于基于模拟的治疗的角膜弹性成像和患者特异性建模
- 批准号:
8664399 - 财政年份:2013
- 资助金额:
$ 40.26万 - 项目类别:
RESOURCE/SERVICE CORE A - OCULAR IMAGING MODULE
资源/服务核心 A - 眼部成像模块
- 批准号:
9153316 - 财政年份:
- 资助金额:
$ 40.26万 - 项目类别:
RESOURCE/SERVICE CORE A - OCULAR IMAGING MODULE
资源/服务核心 A - 眼部成像模块
- 批准号:
9336309 - 财政年份:
- 资助金额:
$ 40.26万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 40.26万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 40.26万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 40.26万 - 项目类别:
Standard Grant